| __timestamp | Ionis Pharmaceuticals, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 49315000 |
| Thursday, January 1, 2015 | 37173000 | 75043000 |
| Friday, January 1, 2016 | 48616000 | 83749000 |
| Sunday, January 1, 2017 | 108488000 | 122682000 |
| Monday, January 1, 2018 | 244622000 | 207761000 |
| Tuesday, January 1, 2019 | 287000000 | 284812000 |
| Wednesday, January 1, 2020 | 354000000 | 317875000 |
| Friday, January 1, 2021 | 186000000 | 282660000 |
| Saturday, January 1, 2022 | 151000000 | 451421000 |
| Sunday, January 1, 2023 | 232600000 | 481871000 |
| Monday, January 1, 2024 | 267474000 |
Unleashing insights
In the competitive world of biotechnology, effective cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry leaders: Sarepta Therapeutics, Inc. and Ionis Pharmaceuticals, Inc., from 2014 to 2023. Over this period, Sarepta's SG&A expenses surged by approximately 878%, peaking in 2023, while Ionis saw a more modest increase of around 105%. Notably, Sarepta's expenses consistently outpaced Ionis, highlighting its aggressive investment in administrative and sales functions. The year 2022 marked a significant leap for Sarepta, with a 60% increase from the previous year, underscoring its strategic expansion efforts. Meanwhile, Ionis experienced a dip in 2021, followed by a recovery in 2023. These trends reflect the dynamic strategies employed by these companies to navigate the ever-evolving biotech landscape.
Johnson & Johnson or Sarepta Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Sarepta Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Pfizer Inc. or Ionis Pharmaceuticals, Inc.
Genmab A/S or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Ascendis Pharma A/S
Sarepta Therapeutics, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Axsome Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Lantheus Holdings, Inc.
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Ionis Pharmaceuticals, Inc. and Soleno Therapeutics, Inc.